v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities    
Net loss $ (65,760) $ (63,105)
Adjustments to reconcile net loss to net cash used in operations:    
Depreciation and amortization 5,246 6,288
Bargain purchase gain, net of tax (1,706)
Gain on disposal of fixed assets (22) (25)
Impairment of intangible assets 3,027
Impairment of operating lease right-of-use assets 406
Impairment of property and equipment 12
Inventory write-downs 127 61
Share-based compensation expense 9,522 11,506
Net accretion of premium on short-term investments (776) (986)
Change in:    
Accounts receivable 717 (740)
Inventory (723) (619)
Other current and non-current assets 606 (3,214)
Accounts payable (784) 896
Accrued liabilities (2,747) 4,321
Contract liabilities and other current liabilities 109 (1,405)
Operating lease liabilities (1,944) (1,813)
Other long-term liabilities (488) 17
Net cash used in operating activities (53,484) (50,512)
Cash flows from investing activities    
Sales of investment securities 28,311 61,700
Purchases of investment securities (25,570) (27,101)
Cash paid for Ibeo business combination (6,300) (11,233)
Purchases of property and equipment (271) (1,981)
Net cash (used in) provided by investing activities (3,830) 21,385
Cash flows from financing activities    
Principal payments under finance leases (19)
Proceeds from stock option exercises 62 175
Net proceeds from issuance of common stock 26,093 60,607
Net cash provided by financing activities 26,155 60,763
Effect of exchange rate changes on cash and cash equivalents and restricted cash 133
Change in cash, cash equivalents, and restricted cash (31,026) 31,636
Cash, cash equivalents, and restricted cash at beginning of period 49,391 21,954
Cash, cash equivalents, and restricted cash at end of period 18,365 53,590
Supplemental schedule of non-cash investing and financing activities    
Amounts issued to escrow for acquisition consideration 3,263
Acquisition of right-of-use asset 1,294
Accrued financing fees 101
Issuance of common stock for subscriptions receivable 323
Foreign currency translation adjustments 101 55
Unrealized loss on investment securities, available-for-sale $ 33 $ 117

Source

HTML PDF
ZIP